Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Assessing VirScan serosurvey epitope profiling variability between in-clinic venous blood draw and capillary blood self-sampling device.
Journal: Microbiology spectrum
Published: April 27, 2026
Antibodies as Therapy: A Coming of Age in Transplantation.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: March 25, 2026
Monoclonal neutralizing antibodies elicited by infection with Kaposi sarcoma-associated herpesvirus reveal critical sites of vulnerability on gH/gL.
Journal: PLoS pathogens
Published: September 09, 2025
Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Clinical and Humoral Risk Factors for Infection.
Journal: Open forum infectious diseases
Published: August 27, 2025
DEVELOPMENT OF A POTENT MONOCLONAL ANTIBODY FOR TREATMENT OF HUMAN METAPNEUMOVIRUS INFECTIONS.
Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025
Development of a potent monoclonal antibody for treatment of human metapneumovirus infections.
Journal: Nature communications
Published: June 10, 2025
Innovation in active and passive immunisation of people who are immunocompromised: a call to action.
Innovation in active and passive immunisation of people who are immunocompromised: a call to action.
Journal: The Lancet. Infectious diseases
Published: February 26, 2025
Author Correction: Production and use of antigen tetramers to study antigen-specific B cells.
Journal: Nature protocols
Published: December 24, 2024
T Cell Immune Response to Influenza Vaccination When Administered Prior to and Following Autologous Chimeric Antigen Receptor-Modified T Cell Therapy.
Journal: Transplantation and cellular therapy
Published: December 11, 2024
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial.
Journal: The Lancet. Infectious diseases
Published: October 01, 2024
Targeting RSV-neutralizing B cell receptors with anti-idiotypic antibodies.
Journal: Cell reports
Published: April 05, 2024
Last Updated: 09/26/2026